Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.90 USD
Change Today -0.16 / -3.16%
Volume 4.0K
EVAR On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 3:48 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

lombard medical inc (EVAR) Snapshot

Open
$4.80
Previous Close
$5.06
Day High
$4.90
Day Low
$4.80
52 Week High
06/12/14 - $7.97
52 Week Low
03/30/15 - $3.55
Market Cap
79.3M
Average Volume 10 Days
10.0K
EPS TTM
$-2.48
Shares Outstanding
16.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LOMBARD MEDICAL INC (EVAR)

Related News

No related news articles were found.

lombard medical inc (EVAR) Related Businessweek News

No Related Businessweek News Found

lombard medical inc (EVAR) Details

Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company’s principal product is Aorfix, which is an endovascular stent-graft for the treatment of an abdominal aortic aneurysm with angulation at the neck of the aneurysm of up to 90 degrees. It is also developing stent-graft system to treat thoracic aortic aneurysms. Lombard Medical, Inc. sells its products directly through its direct sales force and third-party distributors. The company was founded in 2000 and is headquartered in Irvine, California.

192 Employees
Last Reported Date: 04/30/15
Founded in 2000

lombard medical inc (EVAR) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $592.9K
Chief Financial Officer
Total Annual Compensation: $19.4K
President of North America
Total Annual Compensation: $313.1K
Vice President of Global Clinical & Regulator...
Total Annual Compensation: $265.8K
Vice President of Global Innovation and Devel...
Total Annual Compensation: $85.9K
Compensation as of Fiscal Year 2014.

lombard medical inc (EVAR) Key Developments

Lombard Medical, Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-02-2015 04:30 PM

Lombard Medical, Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-02-2015 04:30 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Simon Hubbert, Chief Executive Officer and Director.

Lombard Medical, Inc. Announces Consolidated Unaudited Financial Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Year 2015

Lombard Medical, Inc. announced consolidated unaudited financial results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue was $3,409,000 against $2,058,000 a year ago. Operating loss was $9,757,000 against $7,133,000 a year ago. Loss for the period was $9,543,000 against $6,919,000 a year ago. Total comprehensive loss for the period was $10,930,000 against $6,084,000 a year ago. Basic and diluted loss per ordinary share was $59.0 against $61.9 a year ago. For the 2015, the company reaffirmed that it expects to achieve revenue of between $18 million and $20 million. This growth is expected to result from a more than doubling of the combined number of Aorfix procedures for the company's four large markets (U.S., Japan, UK and Germany) and pricing that remains stable in those markets.

Lombard Medical Closes $26 Million Debt Facility with Oxford Finance

Lombard Medical, Inc. announced that it has entered into a $26 million secured term loan facility with Oxford Finance LLC. Lombard Medical received $11 million in proceeds from the loan at closing on April 24, 2015. The Company has the option of drawing another $10 million after achieving a specific near-term revenue milestone, with a final $5 million becoming available after reaching an additional revenue target.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVAR:US $4.90 USD -0.16

EVAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $23.06 USD -0.18
CryoLife Inc $10.63 USD -0.08
LeMaitre Vascular Inc $10.43 USD +0.45
TriVascular Technologies Inc $5.41 USD +0.11
Vascular Solutions Inc $32.43 USD -0.23
View Industry Companies
 

Industry Analysis

EVAR

Industry Average

Valuation EVAR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.5x
Price/Book 1.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LOMBARD MEDICAL INC, please visit www.lombardmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.